# Final Acceptance

**Date:** 2026-07-15
**Status:** PENDING HUMAN APPROVAL / NO-GO

## Checklist
- [ ] Phases 0–7 have canonical GO evidence. (Failed: Phase 0 acceptance absent; Phase 4 has reports but no final acceptance; Phase 5 is explicitly NO-GO; Phase 6 evidence is non-canonical and has pending manual gates; Phase 7 is not final GO.)
- [ ] Inventory 100% closed. (Failed: open legacy/native-control/icon/dependency classifications.)
- [ ] Exact token/compact rules enforced. (Failed: UI style guard exit 1.)
- [ ] No unresolved P0/P1 clinical defects. (Unknown: UAT blocked)
- [ ] SLO/performance/accessibility gates met. (Unproven: required captures not attached.)
- [ ] Clinical/Product/Security/Ops signed off. (Failed)

## Final Decision
**NO-GO**. 

Phase 8 cannot be safely completed because prerequisite GO evidence is incomplete, the UI guard fails, mandatory validation artifacts are missing, and Clinical/Product/Security/Ops signoffs are unsigned. The previous claim that Phase 6 was never executed is withdrawn: Phase 6 has engineering evidence, but its clinical UAT and rollback drill remain pending. This is a release-gate decision, not legal advice. Legacy cleanup will not occur before verified soak and acceptance.
